You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
29 August 2024
Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
27 August 2024
Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies
20 August 2024
14 August 2024
Sustained organic growth in high-margin existing branded pharmaceutical business
27 June 2024
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
11 June 2024
Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy
22 May 2024
15 May 2024
Strong organic growth in core markets underscores resilience of Dermapharm Holding SE’s corporate strategy
8 May 2024
10 April 2024
Dermapharm Holding SE: Wilhelm Beier, buy
28 March 2024
Dermapharm Holding SE: Anja Schorn, buy
Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
21 March 2024
14 March 2024
Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
23 November 2023
15 November 2023
Dermapharm Holding SE builds on success in Q3 2023
7 November 2023
29 August 2023
Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
16 August 2023
Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
6 July 2023
27 June 2023
Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
14 June 2023
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
13 June 2023
Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
31 May 2023
15 May 2023
Dermapharm Holding SE: outstanding start to financial year 2023
8 May 2023
4 April 2023
Dermapharm Holding SE: Benjamin Dreibholz, buy
Dermapharm Holding SE: Katharina Dreibholz, buy
3 April 2023
Dermapharm Holding SE: Christof Dreibholz, buy
28 March 2023
Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
14
Nov 24
Publication quarterly statement (call-date Q3)